Abstract
We herein present a case of unresectable giant hepatic hemangiomas with Kasabach-Merritt syndrome which was successfully treated by living donor liver transplantation using a left lobe graft. The patient was a 45-year-old woman who complained of abdominal distension. Two sessions of transarterial embolization were performed, but failed to reduce the size of the tumor. The hepatic tumors were thus judged untreatable and the only option for a cure was to offer living donor liver transplantation, because of the tumor size, its location, and the association with Kasabach-Merritt syndrome. A left lobe graft with the middle hepatic vein donated by her 47-year-old brother was transplanted under venovenous bypass. The postoperative course of the recipient was complicated by small-for-size graft syndrome, which developed after episodes of acute cellular rejection on postoperative day 8 and sepsis on day 31. The patient successfully recovered from the complications and was discharged on day 72, and she remains well at 10 months after transplantation. In conclusion, living donor liver transplantation was found to be an effective option for the treatment of a patient with unresectable giant hepatic hemangiomas complicated by Kasabach-Merritt syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995–1013.
Baer HU, Dennison AR, Mouton W, Stain SC, Zimmermann A, Blumgart LH. Enucleation of giant hemangiomas of the liver. Technical and pathologic aspects of a neglected procedure. Ann Surg 1992;216:673–676.
Lise M, Feltrin G, Da Pian PP, Miotto D, Pilati PL, Rubaltelli L, et al. Giant cavernous hemangiomas: diagnosis and surgical strategies. World J Surg 1992;16:516–520.
Inglefield JT Jr, Tisdale PD, Fairchild JP. A case of hemangioma with thrombocytopenia in the newborn infant treated by total excision. Review of the literature. J Pediatr 1961;59:238–242.
Chuang VP, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 1981;140:51–58.
Kawarada Y, Mizumoto R. Surgical treatment of giant hemangioma of the liver. Am J Surg 1984;148:287–291.
McKay MJ, Carr PJ, Langlands AO. Treatment of hepatic cavernous haemangioma with radiation therapy: case report and literature review. Aust N Z J Surg 1989;59:965–968.
Tepetes K, Selby R, Webb M, Madariaga JR, Iwatsuki S, Starzl TE. Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 1995;130:153–156.
Kumashiro Y, Kasahara M, Nomoto K, Kawai M, Sasaki K, Kiuchi T, et al. Living donor liver transplantation for giant hepatic hemangioma with Kasabach-Merritt syndrome with a posterior segment graft. Liver Transpl 2002;8:721–724.
Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizoe S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995;21:1317–1321.
Soejima Y, Harada N, Shimada M, Suehiro T, Minagawa R, Hiroshige S, et al. Perioperative management and complications in donors related to living-donor liver transplantation. Surgery 2002;131:195–199.
McKay MJ, Carr PJ, Langlands AO. Treatment of hepatic cavernous haemangioma with radiation therapy: case report and literature review. Aust N Z J Surg 1989;59:965–968.
Chuang VP, Wallace S. Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 1981;140:51–58.
Stahl RL, Henderson JM, Hooks MA, Martin LG, Duncan A. Therapy of the Kasabach-Merritt syndrome with cryoprecipitate plus intra-arterial thrombin and aminocaproic acid. Am J Hematol 1991;36:272–274.
Larsen EC, Zinkham WH, Eggleston JC, Zitelli BJ. Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics 1987;79:971–980.
Mora A, Cortes C, Roige J, Noguer M, Camps MA, Margarit C. Orthotopic liver transplant for giant cavernous hemangioma and Kasabach-Merritt syndrome. Rev Esp Anestesiol Reanim 1995;42:71–74.
Ferraz AA, Sette MJ, Maia M, Lopes EP, Godoy MM, Petribu AT, et al. Liver transplant for the treatment of giant hepatic hemangioma. Liver Transpl 2004;10:1436–1437.
Klompmaker IJ, Sloof MJ, van der Meer J, de Jong GM, de Brujin KM, Bams JL. Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome. Transplantation 1989;48:149–151.
Chui AK, Vass J, McCaughan GW, Sheil AG. Giant cavernous haemangioma: a rare indication for liver transplantation. Aust N Z J Surg 1996;66:122–124.
Russo MW, Johnson MW, Fair JH, Brown RS Jr. Orthotopic liver transplantation for giant hepatic hemangioma. Am J Gastroenterol 1997;92:1940–1941.
Neidhart JA, Roach RW. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis “defensive”? Am J Med 1982;73:434–438.
Warrell RP Jr, Kempin SJ. Treatment of severe coagulopathy in the Kasabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med 1985;313:309–312.
Longeville JH, de la Hall P, Dolan P, Holt AW, Lillie PE, Williams JA, et al. Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report. HPB Surg 1997;10:159–162.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meguro, M., Soejima, Y., Taketomi, A. et al. Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: Report of a case. Surg Today 38, 463–468 (2008). https://doi.org/10.1007/s00595-007-3623-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-007-3623-4